Exagen Inc.
XGN
$4.39
$0.081.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.31M | 16.63M | 17.24M | 17.20M | 15.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.31M | 16.63M | 17.24M | 17.20M | 15.50M |
| Cost of Revenue | 7.10M | 7.43M | 7.17M | 6.81M | 6.38M |
| Gross Profit | 10.21M | 9.21M | 10.08M | 10.40M | 9.12M |
| SG&A Expenses | 12.07M | 12.42M | 11.45M | 11.54M | 11.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.72M | 21.61M | 20.34M | 19.83M | 18.86M |
| Operating Income | -3.41M | -4.98M | -3.10M | -2.63M | -3.37M |
| Income Before Tax | -3.93M | -4.66M | -7.09M | -4.40M | -3.75M |
| Income Tax Expenses | 36.00K | 13.00K | 1.00K | 37.00K | -- |
| Earnings from Continuing Operations | -3.97M | -4.67M | -7.09M | -4.44M | -3.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.97M | -4.67M | -7.09M | -4.44M | -3.75M |
| EBIT | -3.41M | -4.98M | -3.10M | -2.63M | -3.37M |
| EBITDA | -2.82M | -4.38M | -2.49M | -2.16M | -2.93M |
| EPS Basic | -0.17 | -0.20 | -0.31 | -0.21 | -0.20 |
| Normalized Basic EPS | -0.13 | -0.17 | -0.12 | -0.11 | -0.13 |
| EPS Diluted | -0.17 | -0.20 | -0.31 | -0.21 | -0.20 |
| Normalized Diluted EPS | -0.13 | -0.17 | -0.12 | -0.11 | -0.13 |
| Average Basic Shares Outstanding | 23.86M | 23.58M | 22.94M | 21.09M | 18.56M |
| Average Diluted Shares Outstanding | 23.86M | 23.58M | 22.94M | 21.09M | 18.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |